COVID-19 vaccination has involved a number of different vaccine constructs and with individuals receiving a varying number of doses and combinations of currently approved vaccines. Presently individuals from the age of 30 or more years can receive a 2nd vaccine booster (4 doses) however effectiveness of available approved vaccines is challenged by the emergence of variants capable of eluding subsequent immunity. Variants that are more easily transmitted between individuals, can cause reinfection and promote changes associated with long COVID. The antibody response generated in response to vaccination, infection or reinfection will depend on several variables including age, gender, pre-existing medical conditions and medications along with the type of vaccine construct received and time since the last vaccination. Currently there is much debate over how long protection following vaccination lasts and possible requirement for upgrades to current vaccines to protect against emerging variants. This project aims to gain insight into antibody responses in both vaccinated individuals and those who have had COVID-19 via medical history and ELISA analysis of antibody responses against both S and N proteins.
Supervisor: Dr Roger Lord
Contact: roger.lord@acu.edu.au
Campus: Brisbane